ArticleOncology research2021

Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy.

Ching-Wen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.